文献速递慢性肾脏病血液净化与透析

睡眠呼吸暂停与晚期肾病患者死亡风险的关联

Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-01-22

该前瞻性队列纳入180例晚期CKD或ESKD患者,通过家庭多导睡眠监测评估睡眠呼吸暂停。中位随访9年期间84例死亡,调整混杂因素后呼吸暂停低通气指数与死亡无显著关联,但基于低氧的指标(血氧饱和度<90%时间比例及平均血氧饱和度)与死亡风险显著相关。

要点

  • 睡眠呼吸暂停在晚期肾病患者中常见,71%存在AHI>5。
  • AHI本身与死亡风险无显著独立关联。
  • 夜间低氧指标与死亡风险显著相关,或为风险分层依据。

核心结论

  • 在晚期CKD和ESKD患者中,基于低氧的睡眠呼吸暂停指标与死亡风险增加显著相关,而AHI与死亡无显著关联。

研究设计与样本

  • 前瞻性队列研究,纳入180例患者(88例CKD 4或5期,92例ESKD),进行家庭多导睡眠监测,从国家死亡索引获取死亡数据,采用Cox比例风险模型分析。

主要发现

  • 中位随访9年期间84例(47%)死亡;71%患者AHI>5,23%患者AHI>30。
  • 调整年龄、性别、种族、糖尿病、BMI、CKD/ESKD状态和肾移植状态后,AHI与死亡无显著关联(AHI>30对比AHI≤5:HR 1.5,95%CI 0.6-4.0;AHI>15-30:HR 2.3,95%CI 0.9-5.9;AHI>5-15:HR 2.1,95%CI 0.8-5.4)。
  • 睡眠时间中血氧饱和度<90%的比例每增加15%,死亡风险显著增加(HR 1.4,95%CI 1.1-1.7,P=0.007);平均血氧饱和度每降低2%,死亡风险显著增加(HR 1.6,95%CI 1.2-2.1,P=0.003)。
  • 睡眠时长、睡眠效率或周期性肢体运动指数与死亡无显著关联。

临床怎么用

  • 对晚期CKD和ESKD患者,评估睡眠呼吸暂停时应关注夜间低氧指标(如血氧饱和度<90%时间比例和平均血氧饱和度),其与死亡风险相关,可能有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: In the general population, sleep disorders are associated with mortality. However, such evidence in patients with CKD and ESKD is limited and shows conflicting results. Our aim was to examine the association of sleep apnea with mortality among patients with CKD and ESKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this prospective cohort study, 180 patients (88 with CKD stage 4 or 5, 92 with ESKD) underwent in-home polysomnography, and sleep apnea measures such as apnea hypopnea index (AHI) and nocturnal hypoxemia were obtained. Mortality data were obtained from the National Death Index. Cox proportional hazard models were used for survival analysis. RESULTS: Among the 180 patients (mean age 54 years, 37% women, 39% with diabetes, 49% CKD with mean eGFR 18±7 ml/min per 1.73 m2), 71% had sleep apnea (AHI>5) and 23% had severe sleep apnea (AHI>30). Median AHI was 13 (range, 4-29) and was not significantly different in patients with advanced CKD or ESKD. Over a median follow-up of 9 years, there were 84 (47%) deaths. AHI was not significantly associated with mortality after adjusting for age, sex, race, diabetes, body mass index, CKD/ESKD status, and kidney transplant status (AHI>30: hazard ratio [HR], 1.5; 95% confidence interval [95% CI], 0.6 to 4.0; AHI >15 to 30: HR, 2.3; 95% CI, 0.9 to 5.9; AHI >5 to 15: HR, 2.1; 95% CI, 0.8 to 5.4, compared with AHI≤5). Higher proportion of sleep time with oxygen saturation <90% and lower mean oxygen saturation were significantly associated with higher mortality in adjusted analysis (HR, 1.4; 95% CI, 1.1 to 1.7; P=0.007 for every 15% higher proportion, and HR, 1.6; 95% CI, 1.2 to 2.1; P=0.003 for every 2% lower saturation, respectively). Sleep duration, sleep efficiency, or periodic limb movement index were not associated with mortality. CONCLUSIONS: Hypoxemia-based measures of sleep apnea are significantly associated with increased risk of death among advanced CKD and ESKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jhamb M, Ran X, Abdalla H, et al. Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol. 2020. PMID: 31969341. doi:10.2215/CJN.07880719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。